Chandler Robinson

Insider Reports History

Entity
Individual
Location
C/O Skokie Blvd., Suite 350, Wilmette, IL
Signature
/s/ Karthik Radhakrishnan , Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chandler Robinson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monopar Therapeutics Chief Executive Officer, Director Common Stock 56.2K $379K $6.74 Sep 30, 2024 Direct
Monopar Therapeutics Chief Executive Officer, Director Common Stock 33.3K $225K $6.74 Sep 30, 2024 Indirect
Monopar Therapeutics Chief Executive Officer, Director Restricted Stock Units 29.8K $201K $6.74 Sep 30, 2024 Direct
Monopar Therapeutics Chief Executive Officer, Director Stock Options 0 May 28, 2024 Direct

Insider Reports Filed by Chandler Robinson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNPR Monopar Therapeutics Sep 30, 2024 3 -$12.9K 4 Oct 2, 2024 Chief Executive Officer, Director
MNPR Monopar Therapeutics Jun 30, 2024 3 -$6.35K 4 Jul 2, 2024 Chief Executive Officer, Director
MNPR Monopar Therapeutics May 28, 2024 2 $84.00 4 May 30, 2024 Chief Executive Officer, Director
MNPR Monopar Therapeutics Mar 31, 2024 3 -$4.88K 4 Apr 2, 2024 Chief Executive Officer, Director
MNPR Monopar Therapeutics Dec 31, 2023 6 -$3.67K 4 Jan 3, 2024 Chief Executive Officer, Director
MNPR Monopar Therapeutics Sep 30, 2023 3 -$4.45K 4 Oct 3, 2023 Chief Executive Officer, Director
MNPR Monopar Therapeutics Jun 30, 2023 3 -$8.78K 4 Jul 3, 2023 Chief Executive Officer, Director
MNPR Monopar Therapeutics Mar 31, 2023 3 -$5.96K 4 Apr 4, 2023 Chief Executive Officer, Director
MNPR Monopar Therapeutics Feb 1, 2023 2 $0 4 Feb 3, 2023 Chief Executive Officer, Director
MNPR Monopar Therapeutics Dec 31, 2022 6 -$16.9K 4 Jan 3, 2023 Chief Executive Officer, Director
MNPR Monopar Therapeutics Sep 30, 2022 3 -$6.2K 4 Oct 3, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Jun 30, 2022 3 -$16.1K 4 Jul 1, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Mar 31, 2022 3 -$2.95K 4 Apr 1, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Feb 2, 2022 2 $0 4 Feb 4, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Jan 1, 2022 3 -$7.47K 4 Jan 4, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Dec 31, 2021 3 -$4.38K 4 Jan 4, 2022 Chief Executive Officer, Director
MNPR Monopar Therapeutics Sep 30, 2021 3 -$5.62K 4 Oct 1, 2021 Chief Executive Officer, Director
MNPR Monopar Therapeutics Jun 30, 2021 3 -$13.6K 4 Jul 2, 2021 Chief Executive Officer, Director